Skip to main content


Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.

$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
How these two FDA-submitted drugs could address this major healthcare need.
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
Our overview of what all of us need to know about one of our most vital organs – our kidneys.
How will a new drug fare in a 4,000-patient, four-year study?
Expansion of the use of Roche’s Lucentis a major step for patients.
Can a drug long-used to treat gout be effective at preventing diabetic kidney disease?
Why these two seemingly different diseases may be more similar than you think.
How a major research study is challenging an outdated FDA restriction.
Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.
The curious milestone of a diabetes anniversary.
On June 11, Glooko and the Joslin Diabetes Center announced the release of their HypoMap software , a cool product that really should be able to identify and help...
Update (1/12/15): Medtronic Diabetes gave an update on their upcoming diabetes device pipeline at the J.P. Morgan Healthcare Conference. The MiniMed 640G is expected to...
In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...
At the end of March, encouraging news about Takeda’s once-daily pill for type 2 diabetes, Nesina (alogliptin), circulated at the American College of Cardiology (ACC)...
On March 18, NeuroMetrix launched the second-generation version of its Sensus pain management device, The Sensus is designed to relieve the pain and numbness often...
In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.
All you need to know about diabetic neuropathy - the facts, prevention, and treatment.
Last month, the Fight4MyFeet campaign launched to increase awareness of diabetic foot ulcers among people with diabetes, including a host of valuable tips on how to...